Irinotecan + targeted therapy vs irinotecan
Tumour response · people with metastatic CRC
Irinotecan + targeted therapy leads to higher overall tumour response compared with irinotecan (high certainty).
1 finding from 1 review
- Second‐line systemic therapy for metastatic colorectal cancer 2017 · Cochrane Headline outcomes onlyRR 3.38 [2.53, 4.52]2 studies · 1758 participantsHigh